Biotechnology
Biota Holdings Limited today announced financial results for the first half of the Company's fiscal 2012. The Company reported a half-year loss of $11 million compared to a net loss of $15.9 million in the corresponding half year. Total revenue was ...
4 hours ago
Pioneers of Molecular Research Take 2012 Vilcek Prizes in Biomedical Science
4 hours ago
WuXi PharmaTech , a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, announced that today it had in a negotiated transaction agreed to purchase ...
5 hours ago
ALPCO Diagnostics was recently appointed as Biomedica Immunoassays' exclusive distributor in Canada.
6 hours ago
At a meeting held today, the Directors increased the Company's quarterly cash dividend by 11.1% to $0.20 per share. The dividend is payable on March 15, 2012 to shareholders of record on March 1, 2012.
15 hours ago
In the past, total arch replacement was considered to be one of the most risky cardiac procedures because the patient had to be put on a heart-lung machine and blood flow to the head and body were temporarily stopped after the patient had been ...
16 hours ago
Aoxing Pharmaceutical Company, Inc. , a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals, today announced its financial and ...
16 hours ago
Amgen Names Michael Severino, M.D., Senior Vice President, Global Development and Corporate Chief Medical Officer
17 hours ago
AMPAC Fine Chemicals LLC , a wholly owned subsidiary of American Pacific Corporation , reports that it has joined Rx-360 as an active member. Rx-360 is a pharmaceutical and biotech industry consortium that was founded by industry leaders to enhance ...
18 hours ago
The American Diabetes Association applauds the U.S. Department of Health and Human Services for providing $10 million in Fiscal Year 2012 funding for the National Diabetes Prevention Program from the Prevention and Public Health Fund.
18 hours ago
Laureate Biopharmaceutical Services, Inc., a full-service biopharmaceutical contract development and manufacturing organization, today announced the appointment of Les Mintzmyer as Vice President, Operations. He will be responsible for continuing ...
20 hours ago
Ablynx , today announced that it has appointed Dr Andreas Menrad as its Chief Scientific Officer.
21 hours ago
Neuralstem, Inc. announced today that it has closed on its previously announced registered direct placement of 5,200,000 shares of common stock at a price of $1.00 per share, and 5,200,000 warrants each with an exercise price of $1.02 per share and ...
21 hours ago
Organovo Holdings, Inc. today announced the successful completion of a merger on February 8, 2012, with Organovo, Inc. , a company focused on the development of three-dimensional bioprinting technology for research and medical applications. ...
21 hours ago
Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial
21 hours ago
16 - 30 of 48581 Stories
<<
<
Next 15 Biotechnology
>
>>
Search News
Daily News
